compareglp-1

A comparison studio
Independent editorial information · not individual medical advice

Commercial pages may contain paid referral links. Compare the full payment terms and licensed-care details before enrollment.

Comparison8 min read

Wegovy HD vs Zepbound: Head-to-Head Weight Loss Comparison

Price verification — October 26, 2026

Some examples and provider price illustrations in this article are estimates, not guaranteed checkout quotes.

These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.

For the first time, semaglutide matches tirzepatide in weight loss efficacy. Here's how Wegovy HD stacks up against Zepbound on every metric that matters.

Wegovy HD: Semaglutide 7.2mg — 20.7% weight loss (STEP UP)

Zepbound: Tirzepatide 15mg — 20.9% weight loss (SURMOUNT-1)

The gap: Virtually eliminated at these doses

The Numbers Side by Side

MetricWegovy HD (7.2mg)Zepbound (15mg)
Mean weight loss20.7%20.9%
≥20% weight loss~50%~57%
≥25% weight loss~33%~36%
MechanismGLP-1 single agonistGLP-1/GIP dual agonist
DosingOnce weeklyOnce weekly
Cardiovascular dataYes (SELECT trial)Pending (SURPASS-CVOT)
Available as pillYes (oral Wegovy 25mg)No (orforglipron pending)
Self-pay costTBD (HD), $349+ (standard)$550+

Where Wegovy HD Wins

Where Zepbound Wins

Embody · $149 first mo

Compounded medications are not FDA-approved. Paid link

Compounded Alternatives at Lower Cost

Oak Health Compounded

$130/mo sema

Check Eligibility → Paid link

Compounded medications are not FDA-approved.

Wellorithm Compounded

from $147/mo

Paid link

Compounded medications are not FDA-approved.

Sesame Care Brand-Name

brand-name Rx

Check Eligibility → Paid link

The Bottom Line

The efficacy gap between semaglutide and tirzepatide has essentially closed at their highest approved doses. The decision now comes down to cardiovascular data (advantage: Wegovy), cost (advantage: semaglutide ecosystem), additional indications (advantage: Zepbound for sleep apnea), and oral availability (advantage: Wegovy pill). Both are excellent medications.

Sources

  1. STEP UP trial, semaglutide 7.2mg, 2026
  2. SURMOUNT-1 trial, tirzepatide 15mg, 2022
  3. SURMOUNT-5 head-to-head trial, 2024
  4. SELECT cardiovascular outcomes trial, NEJM 2023

You May Also Like

Free Download

The GLP-1 Cost & Provider Comparison Guide

10 pages breaking down real all-in monthly costs, what drives price differences between providers, and the questions to ask before you commit.